Patient advocacy and access to innovative clinical trials in a changed environment (COVID 19)
1:29:30
Clinical Research Services Webinars
-
Decentralised and hybrid trials - engaging important stakeholders: Patients and investigators
59:47
-
Webinar: Building resilience in pharma R&D by decentralising and digitising
1:00:54
-
Engaging physicians in a healthcare setting to increase research activity
54:46
-
Managing safety reporting in the evolving regulatory environment of the Asia-Pacific region
51:38
-
Imaging AI and machine learning: Beyond the hype
1:02:26
-
Reducing site burden and increasing trial efficiency
55:49
-
Pharmacovigilance compliance and robust oversight at the affiliate level webinar
59:10
-
ICH E9 (R1) Estimands and Sensitivity Analyses in clinical trials
1:05:59
-
Preparing for the new world of drug safety: Embracing cloud and AI
1:01:31
-
In-home visits in clinical trials
58:43
-
Keeping your trial on track in the evolving environment of COVID-19
59:55
-
The Template for a Successful Digital Trial
Industry Leaders Marie Mc Carthy (ICON PLC) and Chen Admati (Intel) explore a few best practices for implementing a successful digital trial
1:00:43
Commercialisation & Outcomes Webinars
-
The value of early-phase medical communication planning
56:53
-
HTA and market access implications for gene therapies learnings for future products
1:03:10
-
Using R Shiny to create interactive and web-based health economic models - challenges and opportunities
1:02:15
-
Health economic assessments in France (CEESP-HAS)
59:03
-
Real world data mapping
59:12
-
Using early scientific advice in drug development: Opportunities and challenges
1:00:28
-
Integrating qualitative patient interviews into a clinical trial protocol
56:34
-
Developing HTA Landscape in APAC
51:33
-
US Payers' perspectives on Digital Therapeutics
49:56
-
Digital Endpoint Strategy and Validation
52:54
-
Survival analysis in HTA submissions
58:38
-
Using Historical Controls in Rare Disease Trials
1:00:35
